| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | WICH complex | 5.75e-05 | 2 | 159 | 2 | GO:0090535 | |
| GeneOntologyCellularComponent | beta-N-acetylhexosaminidase complex | 5.75e-05 | 2 | 159 | 2 | GO:1905379 | |
| GeneOntologyCellularComponent | site of double-strand break | 1.23e-04 | 101 | 159 | 6 | GO:0035861 | |
| GeneOntologyCellularComponent | Wnt signalosome | 2.25e-04 | 16 | 159 | 3 | GO:1990909 | |
| Domain | KRAB | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF816 ZNF480 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 3.67e-07 | 358 | 157 | 15 | PS50805 |
| Domain | KRAB | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF816 ZNF480 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 3.67e-07 | 358 | 157 | 15 | PF01352 |
| Domain | KRAB | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF816 ZNF480 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 5.38e-07 | 369 | 157 | 15 | SM00349 |
| Domain | KRAB | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF816 ZNF480 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 5.57e-07 | 370 | 157 | 15 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF765 ZNF845 ZNF560 ZNF813 ZNF320 ZNF26 ZNF497 ZNF816 ZNF480 ZNF701 ZNF761 ZNF468 ZNF160 | 2.60e-06 | 314 | 157 | 13 | PF13912 |
| Domain | zf-C2H2 | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF497 EGR3 ZNF665 ZNF816 ZNF480 ZNF525 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 5.94e-06 | 693 | 157 | 19 | PF00096 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF765 ZNF845 TUT4 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF497 EGR3 ZNF665 ZNF816 ZNF480 ZNF525 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 8.46e-06 | 777 | 157 | 20 | PS00028 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF497 EGR3 ZNF665 ZNF816 ZNF480 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 2.24e-05 | 694 | 157 | 18 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF497 EGR3 ZNF665 ZNF816 ZNF480 ZNF525 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 2.83e-05 | 775 | 157 | 19 | PS50157 |
| Domain | Znf_C2H2 | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF497 EGR3 ZNF665 ZNF816 ZNF480 ZNF525 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 4.74e-05 | 805 | 157 | 19 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF497 EGR3 ZNF665 ZNF816 ZNF480 ZNF525 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 4.98e-05 | 808 | 157 | 19 | SM00355 |
| Domain | - | ZNF765 ZNF845 ZNF560 ZNF813 ZNF320 ZNF26 ZNF28 ZNF497 EGR3 ZNF665 ZNF816 ZNF480 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 5.93e-05 | 679 | 157 | 17 | 3.30.160.60 |
| Domain | Glycohydro_20b2 | 7.02e-05 | 2 | 157 | 2 | PF14845 | |
| Domain | - | 7.02e-05 | 2 | 157 | 2 | 3.30.379.10 | |
| Domain | Beta_hexosaminidase_sua/sub | 7.02e-05 | 2 | 157 | 2 | IPR025705 | |
| Domain | DVL-1 | 7.02e-05 | 2 | 157 | 2 | IPR008340 | |
| Domain | HEX_eukaryotic_N | 7.02e-05 | 2 | 157 | 2 | IPR029019 | |
| Domain | Chitobiase/Hex_dom_2-like | 7.02e-05 | 2 | 157 | 2 | IPR029018 | |
| Domain | Znf_C2H2-like | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF497 EGR3 ZNF665 ZNF816 ZNF480 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 1.30e-04 | 796 | 157 | 18 | IPR015880 |
| Domain | Peptidase_S28 | 2.09e-04 | 3 | 157 | 2 | IPR008758 | |
| Domain | Glyco_hydro_20_cat | 2.09e-04 | 3 | 157 | 2 | IPR015883 | |
| Domain | Glyco_hydro_20 | 2.09e-04 | 3 | 157 | 2 | PF00728 | |
| Domain | Peptidase_S28 | 2.09e-04 | 3 | 157 | 2 | PF05577 | |
| Domain | Dishevelled | 4.17e-04 | 4 | 157 | 2 | PF02377 | |
| Domain | Dishevelled_fam | 4.17e-04 | 4 | 157 | 2 | IPR008339 | |
| Domain | Dishevelled_protein_dom | 4.17e-04 | 4 | 157 | 2 | IPR003351 | |
| Pubmed | 2.20e-06 | 181 | 161 | 8 | 37372979 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 28728022 | ||
| Pubmed | DMXL2 GBF1 DIS3L DGKD TRIM66 ALMS1 ZNF665 POP1 ZNF160 SCIN HECTD1 TMEM63A | 3.56e-06 | 493 | 161 | 12 | 15368895 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | NRDE2 TUT4 GBF1 MAP1B KDM5A DIS3L DVL1 APC TNRC6B HIRA PPP1CA XRN1 DOCK7 TNS3 | 7.66e-06 | 724 | 161 | 14 | 36232890 |
| Pubmed | SMARCA5 MAP1B DVL1 BAZ1B TNRC6B PPP1CA RAD50 ZZZ3 ALMS1 SYNJ1 XRN1 DOCK7 | 1.05e-05 | 549 | 161 | 12 | 38280479 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 MAP1B KDM5A RALGPS2 APC TBC1D22B PPP1CA ALMS1 FAM13A SYNJ1 XRN1 DOCK7 HECTD1 EPB41L1 TNS3 | 1.24e-05 | 861 | 161 | 15 | 36931259 |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 16710745 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 3013851 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 27881734 | ||
| Pubmed | Liberation of N-acetylglucosamine-6-sulfate by human beta-N-acetylhexosaminidase A. | 2.13e-05 | 2 | 161 | 2 | 6458607 | |
| Pubmed | Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. | 2.13e-05 | 2 | 161 | 2 | 8789434 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 33090377 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 2965147 | ||
| Pubmed | The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis. | 2.13e-05 | 2 | 161 | 2 | 1825792 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12413610 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9694901 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22789865 | ||
| Pubmed | Biochemical consequences of mutations causing the GM2 gangliosidoses. | 2.13e-05 | 2 | 161 | 2 | 10571007 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 7550345 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19166507 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 34201771 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31682993 | ||
| Pubmed | Three novel mutations in Iranian patients with Tay-Sachs disease. | 2.13e-05 | 2 | 161 | 2 | 24518553 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21637923 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 30454891 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9302266 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21997228 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 8896570 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31162334 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 17360567 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 8644734 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 6230359 | ||
| Pubmed | Classification of disorders of GM2 ganglioside hydrolysis using 3H-GM2 as substrate. | 2.13e-05 | 2 | 161 | 2 | 8123671 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9237263 | ||
| Pubmed | NLRP2 is highly expressed in a mouse model of ischemic stroke. | 2.13e-05 | 2 | 161 | 2 | 27693696 | |
| Pubmed | Different expression of beta-N-acetylhexosaminidase in mouse tissues. | 2.13e-05 | 2 | 161 | 2 | 8147878 | |
| Pubmed | Identification of domains in human beta-hexosaminidase that determine substrate specificity. | 2.13e-05 | 2 | 161 | 2 | 8663217 | |
| Pubmed | A genetic association study of NLRP2 and NLRP7 genes in idiopathic recurrent miscarriage. | 2.13e-05 | 2 | 161 | 2 | 23360675 | |
| Pubmed | Pediatric reference data on activity of urinary N-acetyl-β-D-hexosaminidase and its isoenzymes. | 2.13e-05 | 2 | 161 | 2 | 28846871 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 10591618 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9417048 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19126685 | ||
| Pubmed | Physiological substrates for human lysosomal beta -hexosaminidase S. | 2.13e-05 | 2 | 161 | 2 | 11707436 | |
| Pubmed | Promoters for the human beta-hexosaminidase genes, HEXA and HEXB. | 2.13e-05 | 2 | 161 | 2 | 8634145 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 8672428 | ||
| Pubmed | [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis]. | 2.13e-05 | 2 | 161 | 2 | 23370522 | |
| Pubmed | Nlrp2, a maternal effect gene required for early embryonic development in the mouse. | 2.13e-05 | 2 | 161 | 2 | 22295082 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 8673609 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 15953731 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 2971395 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9184660 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 16698036 | ||
| Pubmed | Accumulated α-synuclein affects the progression of GM2 gangliosidoses. | 2.13e-05 | 2 | 161 | 2 | 27453479 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23597150 | ||
| Pubmed | Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb. | 2.13e-05 | 2 | 161 | 2 | 7959736 | |
| Pubmed | KIAA0408 DMXL2 MYOM1 KDM5A DGKD SAMHD1 ALMS1 FTH1 MKLN1 ZNF160 IL6ST | 2.21e-05 | 497 | 161 | 11 | 23414517 | |
| Pubmed | WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. | 2.69e-05 | 13 | 161 | 3 | 16723544 | |
| Pubmed | 2.74e-05 | 418 | 161 | 10 | 34709266 | ||
| Pubmed | HEXB DMXL2 CRIM1 KDM5A DIS3L CNTNAP1 APC AIRE WRAP53 TRIM66 CRNKL1 CELSR3 SYNJ1 VPS35L MKLN1 SENP6 ZNF528 HECTD1 | 3.06e-05 | 1285 | 161 | 18 | 35914814 | |
| Pubmed | 5.71e-05 | 209 | 161 | 7 | 36779422 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HEXA GBF1 DVL1 PTCH1 WRAP53 ADCY9 HIRA CELSR3 SYNJ1 RALGPS1 PPP1R15B LRP5 WDR90 FUT1 HECTD1 GGA1 | 5.88e-05 | 1105 | 161 | 16 | 35748872 |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 22909446 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 36976514 | ||
| Pubmed | Glycosphingolipid degradation and animal models of GM2-gangliosidoses. | 6.37e-05 | 3 | 161 | 2 | 9728335 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 29574422 | ||
| Pubmed | Binding of APC and dishevelled mediates Wnt5a-regulated focal adhesion dynamics in migrating cells. | 6.37e-05 | 3 | 161 | 2 | 20224554 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 22573891 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 1054503 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 9645704 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 22451654 | ||
| Pubmed | Uncoupling of Pyrin-only protein 2 (POP2)-mediated dual regulation of NF-κB and the inflammasome. | 6.37e-05 | 3 | 161 | 2 | 21976665 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 25376457 | ||
| Pubmed | NLRP2 and FAF1 deficiency blocks early embryogenesis in the mouse. | 6.37e-05 | 3 | 161 | 2 | 28630100 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 37273114 | ||
| Pubmed | Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. | 6.37e-05 | 3 | 161 | 2 | 9223328 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 30172704 | ||
| Pubmed | HLA-C expression in extravillous trophoblasts is determined by an ELF3-NLRP2/NLRP7 regulatory axis. | 6.37e-05 | 3 | 161 | 2 | 39052836 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 10579793 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 37499769 | ||
| Pubmed | YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis. | 6.37e-05 | 3 | 161 | 2 | 28130546 | |
| Pubmed | WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. | 6.37e-05 | 3 | 161 | 2 | 19092802 | |
| Pubmed | Non-canonical reader modules of BAZ1A promote recovery from DNA damage. | 6.37e-05 | 3 | 161 | 2 | 29021563 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 15543136 | ||
| Pubmed | A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. | 6.37e-05 | 3 | 161 | 2 | 10021458 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | DMXL2 GBF1 CRIM1 RALGPS2 ADGRB1 BAZ1B WRAP53 ADCY9 HIRA CCDC159 TRIM66 ZZZ3 PIK3CG VPS13A REG3A AGAP9 KNG1 | 6.84e-05 | 1242 | 161 | 17 | 30973865 |
| Pubmed | Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation. | 8.93e-05 | 19 | 161 | 3 | 29514215 | |
| Pubmed | 8.93e-05 | 19 | 161 | 3 | 23912999 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 9.32e-05 | 226 | 161 | 7 | 25900982 | |
| Pubmed | Synergistic activation of the Wnt signaling pathway by Dvl and casein kinase Iepsilon. | 1.27e-04 | 4 | 161 | 2 | 11425858 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 33219123 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 11487578 | ||
| Pubmed | Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses. | 1.27e-04 | 4 | 161 | 2 | 22750073 | |
| Pubmed | Glomerular and tubular damage markers are elevated in patients with diabetes. | 1.27e-04 | 4 | 161 | 2 | 21307379 | |
| Pubmed | The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response. | 1.27e-04 | 4 | 161 | 2 | 23964092 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 19525225 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 8817329 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 1.27e-04 | 4 | 161 | 2 | 9192851 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 27158779 | ||
| Pubmed | Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. | 1.27e-04 | 4 | 161 | 2 | 11212243 | |
| Pubmed | Non-canonical Wnt signaling induces ubiquitination and degradation of Syndecan4. | 1.27e-04 | 4 | 161 | 2 | 20639201 | |
| Cytoband | 19q13.42 | ZNF765 ZNF845 NLRP7 ZNF813 NLRP2 ZNF665 ZNF525 ZNF761 ZNF160 | 6.92e-10 | 125 | 161 | 9 | 19q13.42 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF765 ZNF845 NLRP7 ZNF813 PSMD8 NLRP2 ZNF320 ZNF28 ZNF497 ZNF665 ZNF816 ZNF888 ZNF480 ZNF525 ZNF701 ZNF761 ZNF528 FUT1 ZNF468 ZNF160 | 8.55e-09 | 1192 | 161 | 20 | chr19q13 |
| Cytoband | 19q13.41 | 1.23e-08 | 78 | 161 | 7 | 19q13.41 | |
| Cytoband | 5q13 | 6.21e-05 | 22 | 161 | 3 | 5q13 | |
| Cytoband | 7p14.3 | 3.26e-04 | 38 | 161 | 3 | 7p14.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF765 ZNF845 ZNF560 ZNF177 ZNF813 ZNF320 ZNF26 ZNF28 ZNF497 EGR3 ZNF665 ZNF816 ZNF888 ZNF480 ZNF525 ZNF701 ZNF761 ZNF528 ZNF468 ZNF160 | 1.80e-08 | 718 | 113 | 20 | 28 |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 2.00e-05 | 27 | 158 | 4 | M1391 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 2.00e-05 | 27 | 158 | 4 | MM1135 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN | 3.03e-05 | 200 | 158 | 8 | M330 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN | 3.03e-05 | 200 | 158 | 8 | M6546 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 6.63e-07 | 200 | 160 | 8 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Intermediate|10w / Sample Type, Dataset, Time_group, and Cell type. | 6.63e-07 | 200 | 160 | 8 | e5a8647c47a49c8c90c78d681193946de103d8ff | |
| ToppCell | Transverse-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 6.63e-07 | 200 | 160 | 8 | d89d3c16406d77cb08e1aa00d7df6887a692c337 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.92e-06 | 179 | 160 | 7 | 5be883d7d0be3180bb9844e4a757f0dd247294e4 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.37e-06 | 182 | 160 | 7 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.41e-06 | 188 | 160 | 7 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | tumor_Lung-Myeloid_cells-mo-Mac|tumor_Lung / Location, Cell class and cell subclass | 7.85e-06 | 199 | 160 | 7 | 77d46acf655029eab23471dc4c4a1b0832b24306 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.85e-06 | 199 | 160 | 7 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.85e-06 | 199 | 160 | 7 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.85e-06 | 199 | 160 | 7 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.85e-06 | 199 | 160 | 7 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1-SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 8.11e-06 | 200 | 160 | 7 | e5afd8e2cb2c63899d49fe17011f474d20bb06ea | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 8.11e-06 | 200 | 160 | 7 | c2df917900872453ea17a39928e39d071a6d3339 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.79e-05 | 151 | 160 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-05 | 156 | 160 | 6 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.48e-05 | 160 | 160 | 6 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.48e-05 | 160 | 160 | 6 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.48e-05 | 160 | 160 | 6 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.95e-05 | 165 | 160 | 6 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.49e-05 | 170 | 160 | 6 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-05 | 173 | 160 | 6 | 279efbab7810fa60ab12ea5d09a84800df4adef0 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.24e-05 | 176 | 160 | 6 | 56e19240f4a7b617a986e3c0854b757394e78251 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.24e-05 | 176 | 160 | 6 | c88b46fe29ae7606c8880a6ff0ebb85c0dfda8bd | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 177 | 160 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 177 | 160 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 178 | 160 | 6 | 445fb243d738a34794d66f34b92dde1f3ea6738e | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 179 | 160 | 6 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 180 | 160 | 6 | 5b7d2336ed09d07f6b8dd91c1fa9c5ade633c104 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.95e-05 | 181 | 160 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Lcn2)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.05e-05 | 111 | 160 | 5 | 9ba3590be8862c23b6e2917caed8bdbd9f9c2753 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Lcn2)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.05e-05 | 111 | 160 | 5 | 3e38efb22c47506ef2e2c1e19c79450e11d0ce56 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Lcn2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.05e-05 | 111 | 160 | 5 | cd84f2a9102a6eb63226ecde11d4ece54ff99b48 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-05 | 182 | 160 | 6 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-05 | 182 | 160 | 6 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.43e-05 | 184 | 160 | 6 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | (4)_Mast_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.59e-05 | 185 | 160 | 6 | c91e1081e630a61c18f6af6d198bfcf296746852 | |
| ToppCell | (4)_Mast_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.59e-05 | 185 | 160 | 6 | 3dd5d2237ab50b13a41c12f85e1b79cd72ea567b | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.76e-05 | 186 | 160 | 6 | 88e6246172d816806a498a5c1f38e699f2f5d7c2 | |
| ToppCell | Control-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.98e-05 | 115 | 160 | 5 | cc2f8fb0cbb72b241b65a69195aac0507bddf2e2 | |
| ToppCell | Mild/Remission-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.11e-05 | 188 | 160 | 6 | 614032d18f8060bb12d1af7a1cf1cf4d8b2b505b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 189 | 160 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 190 | 160 | 6 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | Control-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.67e-05 | 191 | 160 | 6 | 33fce8e086601e636e8c6ef2ab58fcfdd52af369 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.67e-05 | 191 | 160 | 6 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.67e-05 | 191 | 160 | 6 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.67e-05 | 191 | 160 | 6 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | 390C-Myeloid-Mast_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.67e-05 | 191 | 160 | 6 | 88bcd0b85b2112cef15c9e44d1429f9fba4a3400 | |
| ToppCell | Control-B_intermediate-14|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.67e-05 | 191 | 160 | 6 | 076302fd247aab6c0b187ac9e0c67a3ba46414ba | |
| ToppCell | 390C-Myeloid-Mast_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.67e-05 | 191 | 160 | 6 | c1517ea7b10a7f732725b4c0224fbfecae80d18b | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-05 | 192 | 160 | 6 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-05 | 192 | 160 | 6 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 193 | 160 | 6 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 193 | 160 | 6 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.27e-05 | 194 | 160 | 6 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 160 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-05 | 194 | 160 | 6 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-05 | 194 | 160 | 6 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.48e-05 | 195 | 160 | 6 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-05 | 195 | 160 | 6 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-05 | 195 | 160 | 6 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-05 | 195 | 160 | 6 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-05 | 195 | 160 | 6 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-05 | 195 | 160 | 6 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-05 | 195 | 160 | 6 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-05 | 197 | 160 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.91e-05 | 197 | 160 | 6 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 7.91e-05 | 197 | 160 | 6 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.91e-05 | 197 | 160 | 6 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.91e-05 | 197 | 160 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.91e-05 | 197 | 160 | 6 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.14e-05 | 198 | 160 | 6 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | C_01|World / shred on cell type and cluster | 8.14e-05 | 198 | 160 | 6 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.14e-05 | 198 | 160 | 6 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.14e-05 | 198 | 160 | 6 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.14e-05 | 198 | 160 | 6 | 641e7be258303bb9782d19fcf8693f317581d3b8 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 8.36e-05 | 199 | 160 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | T_cells-CCR7+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.36e-05 | 199 | 160 | 6 | 467820d6abe3024d9d655b9672c2f9cdc1303db3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | 8.36e-05 | 199 | 160 | 6 | 70b89a930709fdb91fde6f96106add8455b11618 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 8.36e-05 | 199 | 160 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.36e-05 | 199 | 160 | 6 | b51bcbe1675b9665e649a6aa96b1a00575a36093 | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 8.36e-05 | 199 | 160 | 6 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | Mild/Remission-B_intermediate-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.36e-05 | 199 | 160 | 6 | 592111591f0f6816fc56620cb555eb48dabf0758 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1+SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 8.36e-05 | 199 | 160 | 6 | 2cbaef86af870a228cb46895dd765ea8894c83c5 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.36e-05 | 199 | 160 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 54a54ad983503ed515d476882d86b17d97892037 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.36e-05 | 199 | 160 | 6 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | e4be88bcef2738915f711b32c95e9c613e7edf96 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.60e-05 | 200 | 160 | 6 | 33c5615cbedb9e14f4433169babd3a3a51f69b4c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.60e-05 | 200 | 160 | 6 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | COVID-19-Myeloid-MoAM2,_CCL18|COVID-19 / Condition, Lineage and Cell class | 8.60e-05 | 200 | 160 | 6 | b0a50622d00335843efad86bc56a1e910019984b | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 1.07e-04 | 130 | 160 | 5 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 74 | 160 | 4 | 0288a3f4eafbc359d01cde4ba58f946dd07c77cb | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 74 | 160 | 4 | 57884ade66fe39398351685189df5efd7aea0aab | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 74 | 160 | 4 | 13093139a75bfe11f6b032c9fb402efcc703551c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 74 | 160 | 4 | 7f7de9e8142d2435391ee965cee5628e412f0705 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 139 | 160 | 5 | 34398a6f21a1e670497655a7bb7f3cde9e117560 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 139 | 160 | 5 | 450c4152c9fe4ec503271bb3cf93739918c59509 | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; MCF7; HT_HG-U133A | RALGPS2 APC BAZ1B ADCY9 HIRA ALMS1 RALGPS1 ZNF480 ENPEP TMEM63A | 1.07e-06 | 194 | 158 | 10 | 2753_DN |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | RALGPS2 APC ALDH1L1 HIRA TRIM66 METTL25B ALMS1 ZNF480 ZNF160 TMEM63A | 1.35e-06 | 199 | 158 | 10 | 2744_DN |
| Drug | Rolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 6.03e-06 | 185 | 158 | 9 | 3369_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.48e-06 | 190 | 158 | 9 | 4421_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 8.14e-06 | 192 | 158 | 9 | 3729_DN | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.14e-06 | 192 | 158 | 9 | 3313_UP | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A | 9.22e-06 | 195 | 158 | 9 | 5424_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; PC3; HT_HG-U133A | TUT4 RALGPS2 TBC1D22B SVEP1 CRHR2 CELSR3 SYNJ1 PCSK7 TMEM63A | 9.22e-06 | 195 | 158 | 9 | 4016_UP |
| Drug | Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.00e-05 | 197 | 158 | 9 | 5437_DN | |
| Disease | factor XI measurement, Ischemic stroke | 9.33e-05 | 17 | 156 | 3 | EFO_0004694, HP_0002140 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 2.75e-04 | 5 | 156 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | factor XI measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0004694 | |
| Disease | venous thromboembolism | 7.98e-04 | 460 | 156 | 9 | EFO_0004286 | |
| Disease | Hereditary Diffuse Gastric Cancer | 9.80e-04 | 293 | 156 | 7 | C1708349 | |
| Disease | Stomach Neoplasms | 1.06e-03 | 297 | 156 | 7 | C0038356 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.06e-03 | 145 | 156 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of stomach | 1.12e-03 | 300 | 156 | 7 | C0024623 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.31e-03 | 152 | 156 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Childhood Medulloblastoma | 1.53e-03 | 43 | 156 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 1.53e-03 | 43 | 156 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 1.53e-03 | 43 | 156 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 1.53e-03 | 43 | 156 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 1.53e-03 | 43 | 156 | 3 | C0278876 | |
| Disease | basal cell carcinoma (is_implicated_in) | 1.77e-03 | 12 | 156 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | tryptophan betaine measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0021017 | |
| Disease | gallbladder carcinoma (is_marker_for) | 1.77e-03 | 12 | 156 | 2 | DOID:4948 (is_marker_for) | |
| Disease | vascular endothelial function measurement | 1.92e-03 | 99 | 156 | 4 | EFO_0803369 | |
| Disease | liver cirrhosis (implicated_via_orthology) | 2.08e-03 | 13 | 156 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.08e-03 | 13 | 156 | 2 | C1846647 | |
| Disease | Medulloblastoma | 2.37e-03 | 50 | 156 | 3 | C0025149 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 2.42e-03 | 14 | 156 | 2 | EFO_0022085 | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 3.17e-03 | 16 | 156 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 3.27e-03 | 56 | 156 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | partial epilepsy | 3.59e-03 | 17 | 156 | 2 | EFO_0004263 | |
| Disease | Colorectal Carcinoma | CYB5D2 DPYD ZNF560 MAP1B APC ALDH1L1 ZZZ3 VPS13A ZNF480 IL6ST | 4.28e-03 | 702 | 156 | 10 | C0009402 |
| Disease | diet measurement, colorectal cancer | 4.48e-03 | 19 | 156 | 2 | EFO_0008111, MONDO_0005575 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 4.96e-03 | 20 | 156 | 2 | OBA_2045071 | |
| Disease | histidine measurement | 5.20e-03 | 66 | 156 | 3 | EFO_0009769 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FNCEEDPGDTFLKRW | 576 | Q8N1M1 | |
| EGCVNFPSSQVWEKL | 611 | Q7L0X2 | |
| EDCENNPVDSFWKRA | 161 | Q10588 | |
| FKLEWLGNCSGLNDE | 151 | P05026 | |
| LSWQKQQEGCFGEPD | 276 | Q6UX73 | |
| NCDADQPQWRTDKGL | 731 | P78357 | |
| SKQWCEIGFQGDDPK | 156 | Q8N336 | |
| DCETQNPKWASLNLG | 526 | Q5VTM2 | |
| GFSRDLFIQWCQDPK | 336 | Q9P2I0 | |
| CDEDNFGAVIWKETP | 581 | O14514 | |
| TTTPKQGQNLWFLCD | 981 | Q9UIG0 | |
| SGDDQKTESWHCLPQ | 146 | Q8TCU4 | |
| QFPDASGSLKLWCQF | 1486 | Q96L96 | |
| FACGGKLSNWEPKDN | 206 | Q13489 | |
| WCQSVTELKADFPDN | 621 | Q12882 | |
| TPELDCQWDSDNKLS | 676 | Q8TDJ6 | |
| GKAFSDGISWEPQCN | 316 | Q9BYV7 | |
| QDSQWDRKDLGLCFD | 451 | Q8N884 | |
| EKEGCPQAFHALLSW | 51 | O43918 | |
| GCDEVKLTFPDDDWN | 41 | Q6ZP01 | |
| FCHQEDSNWPLSEGK | 156 | Q92878 | |
| FKAIQPEELASCGWS | 66 | Q5JS13 | |
| LAKQEAEWTAGEACP | 1186 | O95153 | |
| SLFAWACQSPLGKED | 231 | Q92621 | |
| PTEGCLKNAQAASWE | 686 | Q86VD1 | |
| ELVNSWKESPLCGDV | 1026 | Q6W4X9 | |
| EAPDLFQWLCSDSLK | 126 | Q96HD1 | |
| PEDCWNKFISNRTLG | 326 | Q96H96 | |
| TFCDADSQKNWLDPS | 141 | Q9H4G0 | |
| LTLFCPEEGDWKNSN | 186 | P46821 | |
| DWTPAVKFACELEGN | 106 | O95050 | |
| LADVAEKWCSNTPFE | 6 | Q8N3F0 | |
| DWGSETKNLEKCNQP | 321 | Q5VYY2 | |
| EGNKLCSVPWTAFRA | 111 | A6NDA9 | |
| TDWGENPKIECANLD | 476 | O75197 | |
| TFPCSNWLDEKKADG | 391 | Q8IVV2 | |
| TFPCGRWLAKNEDDG | 1066 | Q8IVV2 | |
| DNDGWLTSDPRKQCS | 411 | P02675 | |
| GDWSLSQNKSALDCP | 756 | Q16549 | |
| KELDWLSNPSFCVGS | 21 | Q9H7Z3 | |
| NEQCWFGKEPGDLVD | 251 | Q13324 | |
| EPHSWNLKELSDDCF | 381 | P42785 | |
| NLKELSDDCFQQWGV | 386 | P42785 | |
| LATDNQKECEAWPDL | 136 | Q6ZU52 | |
| LNKELDWASINGFCE | 21 | Q9UJY5 | |
| PFWTDLCSIFGSNKD | 686 | Q9NX02 | |
| DTLPCSWQEALDGLK | 46 | Q96FB5 | |
| DICPASEDESGQWKN | 76 | Q07075 | |
| EALTFDPQKGFWCQL | 796 | Q9H3R1 | |
| ADPEDICWKNLSIQG | 401 | O94886 | |
| PQSDLTALCDEKNWE | 561 | O94988 | |
| AEAVNFCTADWLPIG | 581 | P29375 | |
| LWSPACQAFNLDVEK | 31 | P53708 | |
| GKLPECNENSESFLW | 256 | Q9UMZ3 | |
| VLFECSPGNWTDQKK | 881 | Q9ULD6 | |
| LLKQLSAWCGPSSED | 811 | Q99575 | |
| LCDLLWSDPDKDVQG | 201 | P62136 | |
| LQPDWFQCLSDGEVS | 136 | Q9H974 | |
| IKKPDCDDWESGLNA | 86 | P02794 | |
| GPENCTSWIKFAELE | 636 | Q9BZJ0 | |
| ASGALPDWCEQLTSK | 2056 | Q9ULT8 | |
| SDKAPCITDWQQEDG | 461 | P40189 | |
| WACSIFDLKNSLPDA | 191 | Q96N67 | |
| TTGELFLWNKDQDCL | 81 | Q9H799 | |
| WSGNQTLETRDCKPF | 241 | P61567 | |
| DCARKLWIQEGPSAF | 266 | Q9H1K4 | |
| AEKFDLIWNRAQSCP | 181 | Q5TC12 | |
| NFWPDLKAAHELCDS | 191 | Q8TF46 | |
| DSCSEWKPGSLQRFQ | 916 | Q8TF46 | |
| LGKFAFDSPSNWCQD | 86 | Q06889 | |
| CSLGFQSPRKEIQWE | 316 | P51810 | |
| DENWTDDQLLGFKPC | 111 | Q9NZV1 | |
| WDPKFDSVNLEEACL | 91 | O60503 | |
| DNSEDDLEFWNKPCL | 241 | Q86X45 | |
| LNSIDSDGFWKASCP | 301 | Q16760 | |
| DALEWESCFNKVLFP | 1581 | Q92538 | |
| DHLDSGCSQKPWTEQ | 481 | Q8NFN8 | |
| FLFLTPDCKSLWNGD | 211 | P01042 | |
| DNAKLPCFNGRVVSW | 66 | O14640 | |
| SCAFGLKNEEEGPWA | 161 | Q6QHK4 | |
| EFQNKAGVPEDECWT | 506 | Q49AJ0 | |
| WQLETSITKPFDECG | 206 | P54198 | |
| SLDDWKLFATNHPEC | 81 | P36959 | |
| EAQGWLEPDLFNCTS | 2166 | Q9NYQ7 | |
| DNAKLPCFNGRVVSW | 66 | P54792 | |
| LGGDEVEFKCWESNP | 351 | P07686 | |
| NLGWCKLTFPDGQEQ | 501 | Q96MH7 | |
| PFCWEGAQASEALLL | 66 | Q8N697 | |
| NLLFCDDRKNWFSLP | 1396 | Q6ZTR5 | |
| PWCALNGKAEDRESQ | 71 | Q8TDX9 | |
| PQGASGCWKDDLQKE | 211 | P0C7I6 | |
| WEFGTCQPLSDEKDL | 241 | Q9UHL4 | |
| KRPVCDTDQWEFING | 331 | Q8IZK6 | |
| QECLWADSLGPLKDD | 451 | Q8NAC3 | |
| KAIQPDELSSCGWNK | 66 | Q86X27 | |
| GDEVDFTCWKSNPEI | 321 | P06865 | |
| QEATPWKDFALLTQC | 286 | P19526 | |
| WTDADLACQKRPSGN | 61 | Q06141 | |
| WNCNSNDGKDFERKP | 246 | Q969S9 | |
| WSEFSTQPENFLKGC | 161 | Q9BUR4 | |
| QNTDLDELRKCSWPG | 196 | Q9NU19 | |
| DWNKGTNVSFCVLPS | 1521 | O43426 | |
| QWCADRNFTKPQDGD | 571 | Q9Y3Z3 | |
| QTWKLLREDSCNAGP | 436 | Q9UL63 | |
| TEVPLSWDSFNKGDC | 151 | Q9Y6U3 | |
| AKGLNTWSLPNECEK | 106 | Q5QGS0 | |
| PLDCFWEGAKLQSGT | 231 | Q13635 | |
| LCLQTWPEAAGKDSE | 11 | Q9UIB8 | |
| CSFAELISKDWPELQ | 221 | Q8WX94 | |
| EFSECLVNPWSGEAK | 1021 | Q9BZV3 | |
| KPAIENWGSDFLCTE | 1061 | Q6P1J6 | |
| DNDAGGQLPFSKCAW | 781 | Q68CZ2 | |
| LQEKQTFPPCNAEWS | 166 | Q8WUJ1 | |
| ESLKLWNSFCNSDDP | 551 | Q5SWA1 | |
| DKLTCQGNSQWDGPE | 476 | Q4LDE5 | |
| APKLTCQSDGNWDAE | 2926 | Q4LDE5 | |
| PGAWTEACEQKLTFF | 231 | O75891 | |
| CGTLWNLSARNPKDQ | 681 | P25054 | |
| EFSQEEWTCLDPAQK | 16 | Q9H7R5 | |
| EFSQEEWKCLDPAQR | 16 | Q96IR2 | |
| EFSQEEWKCLDPAQR | 16 | Q8N782 | |
| LWLEFKCADPTALSN | 811 | P48736 | |
| GNQKEAPWCFTLDEN | 366 | Q01973 | |
| APWCFTLDENFKSDL | 371 | Q01973 | |
| QDFWRLQAKETFCPE | 66 | Q86WT6 | |
| KSEGCNRSWPFNLEE | 71 | O00584 | |
| DLCFEPAISGAQWAK | 181 | Q96KV7 | |
| PECGKAFSWNSNFLE | 221 | Q6ZNH5 | |
| EFSQEEWKCLDPAQR | 16 | Q86XN6 | |
| EFSQEEWKCLDPAQR | 16 | Q9HCG1 | |
| EFSQEEWKCLDPAQR | 16 | A2RRD8 | |
| GNDKWLSLDLEQCIP | 2331 | Q96RL7 | |
| PENANDTAKETCLNW | 266 | Q7Z3J2 | |
| WLDSDSCQKCDQPFF | 281 | Q96P53 | |
| GDCADWETQLKPKDT | 81 | Q13360 | |
| WKECFLQDPFNRAAG | 646 | Q99797 | |
| NKCLQWPPDNSSFEI | 276 | Q99250 | |
| KEEWVCETGSDNQPL | 11 | P68543 | |
| PTKDDDEFCNIWQSL | 1226 | Q8IZH2 | |
| DDNCSSEIGQWHLKP | 951 | Q9GZR1 | |
| FNQKLEGFTLPRCWE | 956 | P47989 | |
| GQPCIDFLDNPEKWN | 86 | Q5VVX9 | |
| VKDNAGWTPLHEACN | 836 | Q9BQI6 | |
| EFSQEEWKCLDPAQR | 16 | Q6ZN06 | |
| KPAVSGCQEESWLQS | 331 | Q3C1V9 | |
| FSQAEWKCLDPAQRA | 36 | Q8WV37 | |
| EFSQEEWKCLDPAQR | 16 | P0CJ79 | |
| NAKISRQSCPDGWEE | 76 | P17031 | |
| EFSQEEWKCLDPAQR | 16 | Q3MIS6 | |
| EFSQEEWKCLDPAQR | 16 | P17035 | |
| EFSQEEWKCLDPAQR | 16 | Q7L2R6 | |
| LRADPKDFNCWESLG | 591 | Q6PGP7 | |
| EWNRKSPNLSKCGEE | 101 | P48556 | |
| LNWKDSPFLVQCSEC | 41 | A6NDI0 | |
| IEFSQEEWKCLDPAQ | 81 | Q9NV72 | |
| DSWFDTNNCLGDQKL | 366 | O60264 | |
| EPNFWTKQLASLGCI | 251 | O15016 | |
| QWTSKCIAIEDPFDL | 1221 | Q5TAX3 | |
| RLCDDTKPETFNQLW | 641 | Q8IYH5 | |
| EFSQEEWKCLDPAQR | 16 | Q5VIY5 | |
| WLESDSCQKCEQPFF | 281 | Q8IWB7 | |
| ACDNKSNTIEPFWDL | 481 | Q9H0E7 | |
| IEFSLEEWKCLNPAQ | 31 | Q0VGE8 | |
| GPALWQDNFCLKTLN | 186 | Q96MR9 | |
| GNECNLGVWKSDPKA | 251 | Q9UPQ9 | |
| TGAKENFSLDWCKQP | 106 | P23919 | |
| EGKALNLTCNVWGDP | 1586 | P52179 | |
| SDLLESFCIPGLWNE | 201 | Q9BZQ4 |